Jaguar Health Statistics
Total Valuation
Jaguar Health has a market cap or net worth of $2.73 million. The enterprise value is $31.11 million.
Important Dates
The next estimated earnings date is Monday, March 30, 2026, before market open.
| Earnings Date | Mar 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Jaguar Health has 4.54 million shares outstanding. The number of shares has increased by 671.64% in one year.
| Current Share Class | 4.54M |
| Shares Outstanding | 4.54M |
| Shares Change (YoY) | +671.64% |
| Shares Change (QoQ) | +49.11% |
| Owned by Insiders (%) | 20.48% |
| Owned by Institutions (%) | 2.06% |
| Float | 3.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.23 |
| Forward PS | 0.16 |
| PB Ratio | 0.71 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.64 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.81, with a Debt / Equity ratio of 7.32.
| Current Ratio | 0.81 |
| Quick Ratio | 0.14 |
| Debt / Equity | 7.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -411.57% and return on invested capital (ROIC) is -47.65%.
| Return on Equity (ROE) | -411.57% |
| Return on Assets (ROA) | -38.01% |
| Return on Invested Capital (ROIC) | -47.65% |
| Return on Capital Employed (ROCE) | -245.87% |
| Weighted Average Cost of Capital (WACC) | 0.36% |
| Revenue Per Employee | $240,510 |
| Profits Per Employee | -$822,306 |
| Employee Count | 49 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 0.21 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -95.77% in the last 52 weeks. The beta is 0.05, so Jaguar Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.05 |
| 52-Week Price Change | -95.77% |
| 50-Day Moving Average | 0.81 |
| 200-Day Moving Average | 1.92 |
| Relative Strength Index (RSI) | 42.33 |
| Average Volume (20 Days) | 456,239 |
Short Selling Information
The latest short interest is 386,035, so 8.51% of the outstanding shares have been sold short.
| Short Interest | 386,035 |
| Short Previous Month | 502,013 |
| Short % of Shares Out | 8.51% |
| Short % of Float | 12.19% |
| Short Ratio (days to cover) | 0.05 |
Income Statement
In the last 12 months, Jaguar Health had revenue of $11.79 million and -$40.29 million in losses. Loss per share was -$34.74.
| Revenue | 11.79M |
| Gross Profit | 9.65M |
| Operating Income | -32.82M |
| Pretax Income | -41.04M |
| Net Income | -40.29M |
| EBITDA | -30.91M |
| EBIT | -32.82M |
| Loss Per Share | -$34.74 |
Full Income StatementBalance Sheet
The company has $3.53 million in cash and $31.90 million in debt, with a net cash position of -$28.37 million or -$6.25 per share.
| Cash & Cash Equivalents | 3.53M |
| Total Debt | 31.90M |
| Net Cash | -28.37M |
| Net Cash Per Share | -$6.25 |
| Equity (Book Value) | 4.36M |
| Book Value Per Share | 0.85 |
| Working Capital | -6.72M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$26.02 million and capital expenditures -$54,000, giving a free cash flow of -$26.08 million.
| Operating Cash Flow | -26.02M |
| Capital Expenditures | -54,000 |
| Free Cash Flow | -26.08M |
| FCF Per Share | -$5.75 |
Full Cash Flow StatementMargins
| Gross Margin | 81.92% |
| Operating Margin | -278.52% |
| Pretax Margin | -348.22% |
| Profit Margin | n/a |
| EBITDA Margin | -262.27% |
| EBIT Margin | -278.52% |
| FCF Margin | n/a |
Dividends & Yields
Jaguar Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -671.64% |
| Shareholder Yield | -671.64% |
| Earnings Yield | -1,474.72% |
| FCF Yield | -954.45% |
Analyst Forecast
The average price target for Jaguar Health is $60.00, which is 9,863.47% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $60.00 |
| Price Target Difference | 9,863.47% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 24, 2025. It was a reverse split with a ratio of 1:25.
| Last Split Date | Mar 24, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
Jaguar Health has an Altman Z-Score of -12.68 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.68 |
| Piotroski F-Score | 4 |
